Higher Drug Exposure During the First 24 Weeks of Ustekinumab Treatment Is Associated With Endoscopic Remission in Crohn’s Disease

Autor: Van den Berghe, Nathalie, Verstockt, Bram, Vermeire, Séverine, Thomas, Debby, Declerck, Paul
Zdroj: In Clinical Gastroenterology and Hepatology March 2023 21(3):838-840
Databáze: ScienceDirect